This study aimed to identify cell cycle-associated diagnostic biomarkers in sepsis by integrating bulk transcriptomic and single-cell transcriptomic data from public repositories. The investigators first analyzed transcriptomic profiles from the Gene Expression Omnibus (GEO) database to derive differentially expressed genes (DEGs) between sepsis and control samples. These DEGs were overlapped with a curated set of cell cycle–related genes (CCRGs) to produce a list of candidate genes for further evaluation.
Details on the specific GEO datasets, sample sizes, normalization procedures, DEG thresholds, or the source list of CCRGs were not reported in the abstract of the provided source.
Candidate CCRGs were subjected to machine learning–based screening to select a final set of biomarkers. Four genes were prioritized: UPP1, DRAM1, GADD45A, and MAPK14. Expression validation demonstrated these four genes were significantly upregulated in sepsis samples compared with controls. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis; each biomarker achieved high discriminative ability with area under the curve (AUC) values greater than 0.9.
The study therefore proposes these four upregulated genes as potential diagnostic biomarkers that associate cell cycle perturbation with the sepsis transcriptional signature.
To place the biomarkers in biological context, the authors performed gene set enrichment analysis (GSEA). Across the four biomarkers, GSEA identified 65 pathways that were commonly enriched. Representative pathways included toll-like receptor signaling and antigen processing and presentation, both of which are central to innate immune activation and adaptive antigen presentation respectively.
These pathway findings provide computational evidence that the identified cell cycle genes are linked to canonical sepsis-related immune and pathogen-recognition processes, suggesting a possible mechanistic connection between cell-cycle disturbance and sepsis-associated immune dysregulation.
The investigators conducted immune infiltration analysis to assess changes in immune cell composition associated with sepsis. They reported altered infiltration of 14 immune cell subsets in sepsis relative to controls. Notably, there was an increase in neutrophil abundance and a decrease in CD8+ T cell numbers. These shifts are consistent with known sepsis-associated changes in innate and adaptive immune compartments.
The abstract does not provide the full list of the 14 altered cell subsets, the computational method used for deconvolution, nor the quantitative magnitudes of these changes.
Using computational drug prediction linked to the biomarker-associated network, the study identified 19 potential drugs that might interact with the biomarker pathways. Two examples highlighted were doxorubicin hydrochloride and cisplatin, which the authors reported as having dual-targeting capacity in the predicted interactions.
No experimental validation of these drug predictions was reported in the abstract; the list and prediction methods were not detailed in the provided source material.
To map biomarker expression at cellular resolution, the authors integrated single-cell RNA sequencing (scRNA-seq) data for cell annotation and expression analysis. Six immune cell types were annotated in the single-cell datasets. Among these, CD16+ and CD14+ monocytes were identified as key cell populations with respect to the four biomarkers. The authors reconstructed pseudotime differentiation trajectories and observed that expression of UPP1, DRAM1, GADD45A, and MAPK14 increased along monocyte differentiation paths.
These single-cell results indicate that monocyte differentiation states may be a cellular context in which cell cycle–related genes contribute to the sepsis transcriptional program.
The study concludes that four cell cycle–associated biomarkers—UPP1, DRAM1, GADD45A, and MAPK14—are upregulated in sepsis, show high diagnostic potential (AUC > 0.9), and are computationally linked to immune signaling pathways and monocyte differentiation. The findings are presented as computational evidence that cell-cycle disturbance is associated with sepsis-related immune dysfunction and that these biomarkers warrant further experimental validation.
Limitations and caveats reported in the provided source abstract include a lack of detail on cohort composition, exact datasets, and wet-lab validation. The abstract does not report prospective clinical validation, functional experiments confirming causal roles, or safety/efficacy data for the predicted drug interactions; such details were not reported in the provided source.
Overall, this integrated bioinformatics approach highlights cell cycle pathways and monocyte biology as promising areas for follow-up experimental work aimed at biomarker development and mechanistic understanding in sepsis.